Clinical trial
Safety and Efficacy Study of MRE0094 to Treat Chronic, Neuropathic, Diabetic…
NCT00312364 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00312364 |
|---|---|
| Title | Safety and Efficacy Study of MRE0094 to Treat Chronic, Neuropathic, Diabetic Foot Ulcers |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Foot Ulcer, Diabetic, Diabetes Complications |
| Intervention type | Drug |
| Interventions | MRE0094 |
| Enrollment | 322 |
| Start date | Dec 1, 2005 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Apr 10, 2006 |
| Last update posted | Jun 1, 2012 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: